Changes in bioimpedance by age. by Domingos L. S. Rios (20496173)

“…This treatment modality significantly improves anthropometric measurements, glucose, lipids, and inflammatory markers, thereby reducing cardiovascular risk.…”

S1 Data - by Domingos L. S. Rios (20496173)

“…This treatment modality significantly improves anthropometric measurements, glucose, lipids, and inflammatory markers, thereby reducing cardiovascular risk.…”

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Changes in lactate/pyruvate ratio and ketone bodies ratio during CPB. by Vincent Pey (21433304)

Subjects:

Changes in circulatory variables during CPB. by Vincent Pey (21433304)

Subjects:

Analytical framework and statistical methods. by Na Chen (153323)

Subjects:

Average per capita transfer VS share of HH that reduced income. by Na Chen (153323)

Subjects:

Changes in average income reduction rate of households over time across different income groups. by Na Chen (153323)

Subjects:

Evolution of arterial redox potential during CPB. by Vincent Pey (21433304)

Subjects:

Theoretical frameworks of social protection. by Na Chen (153323)

Subjects:

Average per capita transfer amounts in different countries. by Na Chen (153323)

Subjects:

Cohort characteristics. by Vincent Pey (21433304)

Subjects:

Descriptive table of circulatory variables during CPB. by Vincent Pey (21433304)

Subjects:

Mean scores, standard deviations, and significance on key measures and subscales by gender group. by Silas Manning (22693338)

Subjects:

Experimental Design. by Ella Messner (14493059)

Subjects:

Levels of antioxidant enzymes (A) Catalase, (B) Superoxide dismutase, (C) peroxidase. by Hammad Ismail (4227988)

(A) Time taken to reach platform in hidden trail, (B) Time taken to reach platform in visible trail, (C) Latency time to reach platform zone and (D) Time spent in platform zone in... by Hammad Ismail (4227988)

(A) Mobility distance (B) Explored areas, (C) Immobility time for open field test. by Hammad Ismail (4227988)

(A) Time spent in closed arm, (B) Time spent in open arm, (C) Number of entries in closed arm, (D) Number of entries in open arm, and (E) Latency time to enter open arm for elevate... by Hammad Ismail (4227988)